Digital Health
Digital health is one of the fastest growing segments in healthcare and is crowded with companies that make bold claims. How do you add credibility to your claims and get the message out? MacDougall developed the messaging and media campaign for the first FDA approved digital health product.
Featured Case Study
Pear Therapeutics
FDA Approval, product launch and branding
Pear Therapeutics hired MacDougall a week before the company’s expected FDA clearance of their digital therapeutic, reSET, to develop messaging, branding and media outreach for the announcement. Being the first-ever FDA approved digital therapy with therapeutic claims, we developed a brand for the class of drugs, “Prescription Digital Therapeutics,” which was also adopted by the FDA. MacDougall secured coverage in major national and trade news outlets such as CNBC, The Economist, The New York Times, STAT, Teen Vogue, Politico, Endpoints and Xconomy.
Organizations we have served
- Pear Therapeutics
- Click Therapeutics
- Welldoc
- GNS Healthcare
- nference
What we do
Our services
We build brands and implement communications strategies to help achieve your goals and objectives. We intimately know the audiences you want to reach including patients, clinicians, investors, partners, employees and the life science community at large.
